Abstract: Compounds of the formula ##STR1## wherein R.sub.1 is phenyl, halo- and/or methyl-substituted phenyl or pyridinyl;R.sub.2 is hydrogen, straight or branched alkyl of 1 to 4 carbon atoms, 2- or 3-hydroxy-(alkyl of 2 to 3 carbon atoms) or 2- or 3-dimethylamino-(alkyl of 2 to 3 carbon atoms);R.sub.3 is hydrogen or alkyl of 1 to 3 carbon atoms; andR.sub.4 is hydrogen, chlorine or methyl.The compounds are useful as anticonvulsants.
Type:
Grant
Filed:
November 29, 1984
Date of Patent:
August 20, 1985
Assignee:
Dr. Karl Thomae Gesellschaft mit beschranter Haftung
Inventors:
Wolfhard Engel, Eckhart Bauer, Gunter Trummlitz, Peter Danneberg, Joachim Kahling
Abstract: Acylanilides of the formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are substituents defined in claim 1; wherein R.sup.4 is hydrogen or alkyl of up to 4 carbon atoms, or is joined to R.sup.5 as stated below;wherein R.sup.5 is hydrogen, hydroxy, or alkoxy or acyloxy each of up to 15 carbon atoms, or is joined to R.sup.4 to form an oxycarbonyl group such that together with the --N--CO--C-- part of the molecule it forms an oxazolidinedione group;wherein R.sup.6 is alkyl or halogenoalkyl of up to 4 carbon atoms;and wherein R.sup.7 is 5- or 6- membered saturated or unsaturated heterocyclic which contains one, two or three hetero atoms selected from oxygen, nitrogen and sulphur, which heterocyclic may be a single ring or may be fused to a benzo-ring, and which heterocyclic is unsubstituted or bears one or two substituents defined in claim 1;processes for their manufacture and pharmaceutical compositions containing them. The compounds possess antiandrogenic activity.
Abstract: Novel benzo[b]thiophenes, compositions containing same, process for the preparation thereof and methods of reducing blood pressure and producing diuresis by administration of the compounds and compositions are disclosed.
Abstract: Novel heterobicyclic compounds of Formula I, processes for preparing same and pesticidal compositions and methods are described.
Type:
Grant
Filed:
November 2, 1981
Date of Patent:
January 3, 1984
Assignee:
SDS Biotech Corporation
Inventors:
Thomas A. Magee, Robert D. Battershell, Lawrence E. Limpel, Andrew W. Ho, Arthur W. Friedman, H. Glenn Corkins, William W. Brand, Russell Buchman, Louis Storace, Edmond R. Osgood
Abstract: Prostaglandin analogues of the general formula: ##STR1## [wherein the ring A represents: ##STR2## the ring B represents: ##STR3## (wherein R.sup.6 represents hydrogen, methyl or ethyl, and r is zero, one or two), Y represents ethylene, cis- or trans-vinylene or ethynylene, Z represents a grouping of the formula: --(CH.sub.2).sub.m --, --(CH.sub.2).sub.3 --CHR.sup.7 --, --(CH.sub.2).sub.2 --CHR.sup.7 --CH.sub.2 --, --CH.sub.2 --CHR.sup.7 --(CH.sub.2).sub.2 --, --CHR.sup.7 --(CH.sub.2).sub.3 --, or trans--(CH.sub.2).sub.2 --CH.dbd.CH-- (wherein m is 3, 4 or 5, and R.sup.7 represents methyl or ethyl), R.sup.1 represents a grouping of the formula: --COOR.sup.8, ##STR4## or --CH.sub.2 OR.sup.11 (wherein R.sup.8 represents hydrogen, alkyl, aralkyl, cycloalkyl which is unsubstituted or substituted by at least one alkyl group, or R.sup.
Abstract: Stable biologically active 6,9 .alpha.-thiaprostacyclin derivatives having the formula ##STR1## wherein X represents >S, >SO or >SO.sub.2 ;Y represents (E) and(Z)-->C.dbd.CH--CH.sub.2 CH.sub.2 CH.sub.2 COOR,(E)-->CH--CH.dbd.CH--CH.sub.2 CH.sub.2 COOR or >CH--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 COOR; andR represents hydrogen, a pharmaceutically acceptable cation or a pharmaceutically acceptable lower alkyl group.
Type:
Grant
Filed:
March 13, 1978
Date of Patent:
September 22, 1981
Assignee:
Research Corporation
Inventors:
Kyriacos C. Nicolaou, William E. Barnette, Ronald L. Magolda
Abstract: The present invention relates to disperse dyes containing a group of formula I, ##STR1## in which R.sub.1 signifies the atoms necessary to complete an arylene radical, their production and intermediates therefor.
Abstract: Unsaturated alcohols, thiols and thioesters are cyclized by a phenyl selenenyl halide; wherein the conformation flexibility of the unsaturated alcohol, thiol or thioester is selected such that the hydroxy group, thiol group or thioester group is capable of internal addition to at least one unsaturated bond in said alcohol, thiol or thioester; and wherein the ratio of the phenyl selenenyl halide to said unsaturated alcohol, thiol or thioester is 0.9-1.5 to 1. In a preferred embodiment, oxygen isomers and sulfur analogs of prostacyclin of the formula ##STR1## wherein X= ##STR2## Y=(E)- and (Z)- >C.dbd.CH--CH.sub.2 CH.sub.2 CH.sub.2 COOR; (E)- >CH--CH.dbd.CH--CH.sub.2 CH.sub.2 COOR; andR=any pharmaceutically acceptable cation or lower alkyl group comprising 1 to 4 carbon atoms are formed by:(1) cyclizing a PGF.sub.2.alpha. prostaglandin derivative or a 9.alpha. thio or 9.alpha. -thioester analog of prostaglandin PGF.sub.2.alpha.
Type:
Grant
Filed:
March 13, 1978
Date of Patent:
March 24, 1981
Assignee:
Research Corporation
Inventors:
Kyriacos C. Nicolaou, William E. Barnette, Ronald L. Magolda, Zenon Lysenko